G KEARNS

604 total citations
22 papers, 392 citations indexed

About

G KEARNS is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Infectious Diseases. According to data from OpenAlex, G KEARNS has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 4 papers in Infectious Diseases. Recurrent topics in G KEARNS's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). G KEARNS is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). G KEARNS collaborates with scholars based in United States, Russia and Netherlands. G KEARNS's co-authors include Jean S. Marshall, Russell Gotschall, Susan M. Abdel‐Rahman, Laura P. James, R. F. Jacobs, Jeffrey L. Blumer, J. A. Hinson, Lynda Letzig, Dean W. Roberts and James D. Marshall and has published in prestigious journals such as The Journal of Pediatrics, Clinical Pharmacology & Therapeutics and The Pediatric Infectious Disease Journal.

In The Last Decade

G KEARNS

22 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G KEARNS United States	10	136	97	75	72	54	22	392
Nicole R. Zane United States	12	59 0.4×	80 0.8×	111 1.5×	85 1.2×	42 0.8×	21	364
Jennifer J. Harris United States	10	103 0.8×	62 0.6×	92 1.2×	29 0.4×	84 1.6×	10	430
Madhusudana R. Chaluvadi United States	6	154 1.1×	71 0.7×	72 1.0×	44 0.6×	74 1.4×	9	430
Roselyne Bidault France	13	87 0.6×	200 2.1×	89 1.2×	70 1.0×	47 0.9×	16	500
Fabrizio Nicolis Italy	11	136 1.0×	72 0.7×	96 1.3×	72 1.0×	48 0.9×	32	509
Jill Fiedler‐Kelly United States	13	51 0.4×	101 1.0×	161 2.1×	158 2.2×	110 2.0×	47	653
Christoph Markert Germany	10	134 1.0×	70 0.7×	65 0.9×	65 0.9×	60 1.1×	16	466
Phylinda L. S. Chan United States	13	49 0.4×	68 0.7×	88 1.2×	60 0.8×	55 1.0×	22	493
Rianto Setiabudy Indonesia	13	134 1.0×	108 1.1×	55 0.7×	38 0.5×	115 2.1×	78	604
Malcolm D. Eve United Kingdom	8	95 0.7×	119 1.2×	79 1.1×	168 2.3×	61 1.1×	8	500

Countries citing papers authored by G KEARNS

Since Specialization

Citations

This map shows the geographic impact of G KEARNS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G KEARNS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G KEARNS more than expected).

Fields of papers citing papers by G KEARNS

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G KEARNS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G KEARNS. The network helps show where G KEARNS may publish in the future.

Co-authorship network of co-authors of G KEARNS

This figure shows the co-authorship network connecting the top 25 collaborators of G KEARNS. A scholar is included among the top collaborators of G KEARNS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G KEARNS. G KEARNS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

KEARNS, G. (2015). Selecting the proper pediatric dose: It is more than size that matters. Clinical Pharmacology & Therapeutics. 98(3). 238–240. 10 indexed citations

KEARNS, G, et al.. (2010). Histamine: New Thoughts About a Familiar Mediator. Clinical Pharmacology & Therapeutics. 89(2). 189–197. 58 indexed citations

Smith, Ned B., et al.. (2008). Reduced Activities of Cytochrome P450 1A2 and Xanthine Oxidase in Children With Growth Hormone Deficiency. Clinical Pharmacology & Therapeutics. 84(6). 674–678. 6 indexed citations

Letzig, Lynda, et al.. (2008). Acetaminophen-Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose. Clinical Pharmacology & Therapeutics. 84(6). 684–690. 52 indexed citations

Blake, M. Brian, et al.. (2006). OII-C-1Effect of diet on the ontogeny of caffeine and dextromethorphan metabolism. Clinical Pharmacology & Therapeutics. 79(2). P6–P6. 2 indexed citations

Davis, Donald R., William M. Pierce, Tung‐Yi Lin, et al.. (2006). LBOVI-B-4Recombinant human growth hormone (rhGH) has no effect on activities of hepatic cytochrome P4501A2 (CYP1A2), N-acetyltransferase 2 (NAT2), xanthine oxidase (XO) or cytochrome P4502D6 in children with idiopathic growth hormone (GH) deficiency. Clinical Pharmacology & Therapeutics. 79(2). P84–P84. 1 indexed citations

Blake, M. Brian, et al.. (2005). Pharmacokinetics of rifapentine in children. Clinical Pharmacology & Therapeutics. 77(2). P30–P30. 1 indexed citations

KEARNS, G, et al.. (2000). Single dose pharmacokinetics of linezolid in infants and children. The Pediatric Infectious Disease Journal. 19(12). 1178–1184. 68 indexed citations

Komoroski, Richard A., et al.. (2000). The Use of Nuclear Magnetic Resonance Spectroscopy in the Detection of Drug Intoxication. Journal of Analytical Toxicology. 24(3). 180–187. 15 indexed citations

10.

Marshall, James D., et al.. (2000). Pediatric Pharmacodynamics of Midazolam Oral Syrup. The Journal of Clinical Pharmacology. 40(6). 578–589. 13 indexed citations

11.

Gaedigk, Andrea, et al.. (1999). Acquistion of functional CYP2D6 activity in the first year of life1. Clinical Pharmacology & Therapeutics. 65(2). 176–176. 1 indexed citations

12.

Marshall, Jean S. & G KEARNS. (1999). Developmental pharmacodynamics of cyclosporine. Clinical Pharmacology & Therapeutics. 66(1). 66–75. 43 indexed citations

13.

Streetman, Daniel S., A NAFZIGER, J. Steven Leeder, et al.. (1999). Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping. Clinical Pharmacology & Therapeutics. 66(5). 535–541. 17 indexed citations

14.

KEARNS, G, et al.. (1999). Pharmacokinetics (PK) of pleconaril (PLEC) in neonates1. Clinical Pharmacology & Therapeutics. 65(2). 140–140. 1 indexed citations

15.

Marcucci, Kenda, et al.. (1999). Inhibition of cytochrome P4502D6 (CYP2D6) by terbinafine (TER) in vitro. Clinical Pharmacology & Therapeutics. 65(2). 135–135. 4 indexed citations

16.

Gotschall, Russell, et al.. (1999). Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clinical Pharmacology & Therapeutics. 65(5). 465–472. 66 indexed citations

17.

KEARNS, G, et al.. (1999). CYP2C9 genotype and ibuprofen (IBU) pharmacokinetics (PK) in cystic fibrosis (CF)1. Clinical Pharmacology & Therapeutics. 65(2). 140–140. 1 indexed citations

18.

Johnson, Keith, et al.. (1999). Children in research speak for themselves. Clinical Pharmacology & Therapeutics. 65(2). 176–176. 1 indexed citations

19.

Kashuba, Angela D. M., A NAFZIGER, G KEARNS, et al.. (1999). Dextromethorphan (DM) N-demethylation (N-D) does not accurately reflect hepatic CYP3A phenotype. Clinical Pharmacology & Therapeutics. 65(2). 170–170. 3 indexed citations

20.

Marshall, James D., Henry C. Farrar, & G KEARNS. (1995). Diarrhea associated with enteral benzodiazepine solutions. The Journal of Pediatrics. 126(4). 657–659. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact